Feel Better Guide — ARA-290 16 mg

ARA-290 (Cibinetide) · 16 mg vial · mixed with 2 mL BAC water

Informational only — not medical advice. I'm not a doctor, just a girl sharing what's helped me and the people I care about.

Quick Facts

What Is It?

ARA-290, also known as cibinetide, is an 11-amino-acid peptide derived from erythropoietin (EPO). It was deliberately designed to keep EPO's tissue-protective and anti-inflammatory effects without stimulating red blood cell production.

It's been studied in humans with small-fiber neuropathy related to sarcoidosis and type 2 diabetes, with improvements reported in neuropathic symptoms and in measures of nerve health. It remains experimental and is not an FDA-approved treatment.

Who May Benefit?

This one is worth a look when pain seems nerve-related rather than simply muscular or inflammatory:

• Neuropathic or nerve-related pain
• Burning, tingling or hypersensitivity
• Small-fiber neuropathy
• Nerve inflammation
• Tissue protection and repair

Benefits

ARA-290 is being researched for its ability to:

• Reduce neuroinflammation
• Calm abnormal nerve-pain signaling
• Protect injured nerve cells
• Support small nerve-fiber recovery
• Improve burning, tingling and hypersensitivity associated with neuropathy
• Support tissue repair after inflammation or injury

How It Works

ARA-290 activates a tissue-protective receptor system often called the innate repair receptor.

Rather than acting like a traditional pain medication, it appears to influence a sequence:

Inflammation → Cell protection → Repair → Nerve recovery

And it was intentionally developed so that it would not have the red-blood-cell-producing effect associated with EPO.

What to Expect

This is generally not something I'd expect anyone to feel immediately.

Week 1 — there may be little or no noticeable change.

Weeks 2–4 — this is when I'd start watching for less burning, less stabbing or electric-type pain, reduced scalp or skin sensitivity, less tingling, better tolerance of touch or pressure, and improved comfort or function.

4+ weeks — a much better point to evaluate whether it's actually doing anything meaningful.

Because the goal may involve genuine nerve recovery rather than simply numbing pain, improvement can be gradual.

💛 T's Tip

This one caught my attention because it's a little different from most of the recovery peptides we talk about, babe. I get especially interested when someone describes their pain as burning, stabbing, electric, tingling, or so sensitive they can't stand being touched — all the things that make me think there's a nerve component rather than a muscle one.

I also want to be straight with you: this one is experimental. We have some encouraging human research, particularly in small-fiber neuropathy, but we do not have studies proving it works for every type of nerve pain.

So my expectation wouldn't be "take a shot and see how you feel tomorrow." It would be: is that irritated nerve gradually becoming less angry over several weeks? That's what I'd be watching for. 💛 — T

Mixing

Add 2 mL BAC water to the 16 mg vial, slowly, down the inside wall. Swirl gently until clear — never shake — and refrigerate.

At this mix, 16 mg ÷ 2 mL = 8 mg per mL, so 1 unit = 0.08 mg.

Dosing (not medical advice)

What one 16 mg vial actually gives you — worth looking at first, because it shapes everything else:

About the research dose. A commonly cited Phase II regimen was 4 mg subcutaneously once daily for 28 days. Be aware what that means in practice: 28 days at 4 mg is 112 mg — seven vials. One vial covers four days of it.

That gap is the honest reason most people run this one lower, or shorter, or both. There's no protocol that says a smaller dose over more days works as well — there simply isn't the research to say either way. It's a judgment call, and I'd rather tell you that than pretend otherwise.

⚠️ Please read this before you plan anything. The 4 mg daily dose is a clinical-research dose, not an FDA-approved dosing recommendation. There is no established medical dosing protocol for ARA-290 for occipital neuralgia, tension headaches, neck pain, injury recovery, or general wellness. Text me before you start and we'll think it through together.

How Long Will One Vial Last?

One 16 mg vial holds 200 total units — 16 doses at 1 mg, 8 at 2 mg, about 5 at 3 mg, or 4 at 4 mg.

At 1 mg daily, a single vial covers a bit over two weeks. At 4 mg daily it's four days. Decide which end of that range you're aiming for before you mix the vial, because once it's reconstituted the clock is running.

Side Effects

ARA-290 was generally well tolerated in the small human trials conducted so far, but the overall human safety database is still limited. Possible effects:

• Injection-site irritation
• Headache
• Fatigue
• Dizziness
• Temporary irritation or discomfort

Unlike EPO, ARA-290 was developed specifically not to stimulate red blood cell production.

Storage

Refrigerate the reconstituted vial (36–46°F / 2–8°C). Don't shake it. Swab the stopper each time and use a fresh sterile syringe.

Helpful Tips

• Give it time. For nerve-related issues, judge progress over weeks, not individual days.
• Track the symptom that actually matters. Instead of just "does it hurt?", watch for: Can I sleep with my head on the pillow? Can I wear a hat comfortably? Is the stabbing happening less often? Is touch less irritating? Is the intensity lower? Am I reaching for rescue medication less? Those are far easier to notice than waiting for pain to vanish completely.
• One change at a time. Starting several new peptides at once makes it nearly impossible to know what helped.
• Don't ignore the cause. ARA-290 shouldn't replace being evaluated for nerve compression, cervical-spine problems, occipital neuralgia, or another underlying cause of persistent neuropathic pain.
• Inject sub-Q; rotate injection sites.

FAQ

Can I combine this with my other peptides? Using more than one peptide is common and perfectly fine — but different peptides should not be combined in the same syringe. A few technically can be mixed, but they don't always play well together, and in some cases they can work against each other, so you lose the benefit of both. It isn't worth the guesswork. Keep each peptide in its own syringe — you can still take them in the same sitting, one right after another. When in doubt, keep them separate.

ARA-290 or BPC-157 / TB-500? They're not interchangeable — they target different proposed pathways. BPC-157 / TB-500 is more interesting when there's a soft-tissue, tendon, ligament or muscular injury component. ARA-290 is more interesting when the dominant symptoms are burning, stabbing, electric, tingling or hypersensitive — the strongly nerve-like ones. If your problem has both components, that's a conversation to have.

Will it raise my red blood cell count like EPO? No. It was specifically designed not to do that — that's the whole point of the molecule.

How long before I know if it's working? Give it four weeks minimum before evaluating. Week 1 is usually quiet.

Is this FDA approved? No. It's experimental, the human safety database is limited, and there's no established dosing protocol outside of research. Please have this one in a conversation with your own provider.

A Little Reminder

This isn't about perfection, it's about consistency. Nerve pain is exhausting in a way that's hard to explain to people who haven't had it, and slow improvement still counts as improvement. You're not lazy and you're not broken. I'm really glad you're here. 💛

Informational only. This is not medical advice, diagnosis, or treatment. Peptides discussed are for research/educational purposes. ARA-290 is experimental and is not FDA approved for any condition. Please work with a licensed clinician for anything specific to you.